FMR LLC - TRAVERE THERAPEUTICS INC ownership

TRAVERE THERAPEUTICS INC's ticker is TVTX and the CUSIP is 89422G107. A total of 174 filers reported holding TRAVERE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.74 and the average weighting 0.1%.

Quarter-by-quarter ownership
FMR LLC ownership history of TRAVERE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$767,579
-19.0%
85,859
+39.2%
0.00%
Q2 2023$947,466
-90.2%
61,684
-85.7%
0.00%
Q1 2023$9,704,884
+156.1%
431,520
+139.5%
0.00%
Q4 2022$3,788,912
-63.3%
180,167
-57.0%
0.00%
-100.0%
Q3 2022$10,322,000
-2.9%
418,905
-4.5%
0.00%0.0%
Q2 2022$10,632,000
-1.3%
438,814
+4.9%
0.00%0.0%
Q1 2022$10,777,000
-6.9%
418,184
+12.1%
0.00%0.0%
Q4 2021$11,576,000
+28.0%
372,9280.0%0.00%0.0%
Q3 2021$9,044,000
+4952.5%
372,928
+2932.2%
0.00%
Q2 2021$179,000
-98.8%
12,299
-97.9%
0.00%
-100.0%
Q1 2021$14,972,000
-17.7%
599,599
-10.2%
0.00%
-50.0%
Q4 2020$18,193,000667,4990.00%
Other shareholders
TRAVERE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Lynx1 Capital Management LP 411,680$10,609,0009.85%
VR Adviser, LLC 1,994,997$51,411,0008.33%
Kynam Capital Management, LP 870,918$22,444,0007.28%
GREAT POINT PARTNERS LLC 1,010,000$26,028,0006.29%
Deep Track Capital, LP 3,134,503$80,776,0005.18%
RA Capital Management 4,922,941$126,864,0002.77%
ARMISTICE CAPITAL, LLC 4,958,000$127,768,0002.47%
MPM BioImpact LLC 277,950$7,163,0001.92%
Sofinnova Investments, Inc. 658,249$16,963,0001.29%
Perceptive Advisors 1,845,555$47,560,0000.95%
View complete list of TRAVERE THERAPEUTICS INC shareholders